author-photo

L. Mccasland

1

Papers

2

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

AB0559 EFFICACY AND SAFETY OF RISANKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AFTER INADEQUATE RESPONSE OR INTOLERANCE TO DMARDs: 24-WEEK RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND KEEPsAKE 1 TRIAL

2021 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (2)